Hayes Christopher G. — SEC Form 4 filings

SEC reporting owner CIK 1805359. 6 Form 4 filings on record with FilingPulse; latest filed 2025-03-18.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-19 to 2025-03-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Verrica Pharmaceuticals Inc. (VRCA)CHIEF LEGAL OFFICER65 legs · 61,768 sh · $249,3725

Form 4 filings — Hayes Christopher G.

FiledFormIssuerReported transactionsSource
2025-03-184Verrica Pharmaceuticals Inc. (VRCA)Sale (S): 4,315 @ $0.65 · Grant/award (A): 250,000 (derivative) @ $0EDGAR
2025-02-064/AVerrica Pharmaceuticals Inc. (VRCA)Grant/award (A): 150,000 @ $0EDGAR
2024-10-114Verrica Pharmaceuticals Inc. (VRCA)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-08-284Verrica Pharmaceuticals Inc. (VRCA)Sale (S): 26,183 @ $2.66 · Sale (S): 9,530 @ $2.46EDGAR
2024-07-234Verrica Pharmaceuticals Inc. (VRCA)Sale (S): 21,649 @ $7.06 · Sale (S): 91 @ $6.98EDGAR
2024-03-194Verrica Pharmaceuticals Inc. (VRCA)Grant/award (A): 40,000 @ $0 · Grant/award (A): 80,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1805359 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →